Forvis Mazars Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,626
Closed -$360K 296
2019
Q3
$360K Sell
3,626
-782
-18% -$74.3K 0.03% 209
2019
Q2
$407K Sell
4,408
-116
-3% -$11K 0.03% 183
2019
Q1
$427K Buy
4,524
+336
+8% +$29.4K 0.04% 179
2018
Q4
$268K Buy
4,188
+658
+19% +$48.6K 0.03% 191
2018
Q3
$316K Sell
3,530
-188
-5% -$16.6K 0.03% 189
2018
Q2
$295K Buy
3,718
+8
+0.2% +$664 0.03% 197
2018
Q1
$331K Buy
3,710
+226
+6% +$21.7K 0.03% 187
2017
Q4
$364K Sell
3,484
-418
-11% -$47.2K 0.04% 181
2017
Q3
$569K Sell
3,902
-19
-0.5% -$2.59K 0.06% 126
2017
Q2
$509K Buy
3,921
+104
+3% +$12.7K 0.06% 136
2017
Q1
$475K Buy
3,817
+133
+4% +$15.9K 0.06% 128
2016
Q4
$426K Buy
3,684
+141
+4% +$15.7K 0.06% 132
2016
Q3
$370K Buy
3,543
+445
+14% +$48.2K 0.05% 130
2016
Q2
$306K Buy
3,098
+3
+0.1% +$310 0.05% 139
2016
Q1
$310K Sell
3,095
-1,155
-27% -$119K 0.05% 138
2015
Q4
$509K Sell
4,250
-248
-6% -$28.7K 0.08% 109
2015
Q3
$487K Buy
4,498
+355
+9% +$44.1K 0.09% 107
2015
Q2
$479K Sell
4,143
-2
-0% -$229 0.07% 112
2015
Q1
$478K Buy
4,145
+73
+2% +$8.72K 0.07% 112
2014
Q4
$455K Buy
+4,072
New +$429K 0.07% 102

Other funds holding CELG

Forvis Mazars Wealth Advisors's CELG Position: Q4 2019 in Review

Forvis Mazars Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,626 shares — an estimated $360K sold.

Forvis Mazars Wealth Advisors first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $569K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Forvis Mazars Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Forvis Mazars Wealth Advisors sold 3,626 Celgene Corp shares in Q4 2019, an estimated $360K.
  • Forvis Mazars Wealth Advisors first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • Forvis Mazars Wealth Advisors's Celgene Corp position peaked at $569K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q4 2019, filed 13 Jan 2020.